Equity Overview
Price & Market Data
Price: $0.54
Daily Change: -$0.0162 / 3.00%
Range: $0.525 - $0.578
Market Cap: $5,156,892
Volume: 250,299
Performance Metrics
1 Week: -30.91%
1 Month: -34.38%
3 Months: -89.22%
6 Months: -94.92%
1 Year: -99.83%
YTD: -92.14%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in Naples, Florida.